Quantitative FRET Imaging to Visualize the Invasiveness of Live Breast Cancer Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Lu, Shaoying ^a   Wang, Yi ^a   Huang, He ^a   Pan, Yijia ^b   Chaney, Eric J ^a,b   Boppart, Stephen A ^a,b   Ozer, Howard ^c   Strongin, Alex Y ^d   Wang, Yingxiao ^a,b,e  

^a University of Illinois at Urbana Champaign   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d BURNHAM INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE;

AMINO ACID SEQUENCE; ARTICLE; BIOSENSOR; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; COLLAGEN DEGRADATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FLUORESCENCE RESONANCE ENERGY TRANSFER; PROTEIN CLEAVAGE; QUANTITATIVE ANALYSIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

BIOSENSING TECHNIQUES; BREAST NEOPLASMS; CELL ADHESION; CELL SURVIVAL; COLLAGEN; FIBRONECTINS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MATRIX METALLOPROTEINASE 14; MCF-7 CELLS; MOLECULAR IMAGING; NEOPLASM INVASIVENESS; PROTEOLYSIS; UP-REGULATION;

EID: 84874895512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058569     Document Type: Article

References (56)

1. Kessenbrock K, Plaks V, Werb Z, (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
2. Strongin AY, (2010) Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim Biophys Acta 1803: 133-141.
3. Martin MD, Matrisian LM, (2007) The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 26: 717-724.
4. Gutierrez-Fernandez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, et al. (2008) Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res 68: 2755-2763.
5. Palavalli LH, Prickett TD, Wunderlich JR, Wei X, Burrell AS, et al. (2009) Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet 41: 518-520.
6. Coussens LM, Fingleton B, Matrisian LM, (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
7. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, et al. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
8. Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, et al. (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 167: 769-781.
9. Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ, (2000) Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 149: 1309-1323.
10. Sabeh F, Shimizu-Hirota R, Weiss SJ, (2009) Protease-dependent versus-independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 185: 11-19.
11. Kachgal S, Carrion B, Janson IA, Putnam AJ, (2012) Bone marrow stromal cells stimulate an angiogenic program that requires endothelial MT1-MMP. J Cell Physiol 227: 3546-3555.
12. Seiki M, (2003) Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 194: 1-11.
13. Egeblad M, Werb Z, (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
14. Apte SS, Fukai N, Beier DR, Olsen BR, (1997) The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis. J Biol Chem 272: 25511-25517.
15. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M, (1996) Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393: 101-104.
16. Yana I, Weiss SJ, (2000) Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 11: 2387-2401.
17. Golubkov VS, Chekanov AV, Shiryaev SA, Aleshin AE, Ratnikov BI, et al. (2007) Proteolysis of the membrane type-1 matrix metalloproteinase prodomain: implications for a two-step proteolytic processing and activation. J Biol Chem 282: 36283-36291.
18. Osenkowski P, Toth M, Fridman R, (2004) Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J Cell Physiol 200: 2-10.
19. Remacle A, Murphy G, Roghi C, (2003) Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface. J Cell Sci 116: 3905-3916.
20. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, et al. (2006) Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med 17: 583-590.
21. Sroka IC, Nagle RB, Bowden GT, (2007) Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells. Neoplasia 9: 406-417.
22. Nagakawa O, Murakami K, Yamaura T, Fujiuchi Y, Murata J, et al. (2000) Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines. Cancer Lett 155: 173-179.
23. Itoh Y, Seiki M, (2006) MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 206: 1-8.
24. Perentes JY, Kirkpatrick ND, Nagano S, Smith EY, Shaver CM, et al. (2011) Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors. Cancer Res 71: 4527-4538.
25. Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Iwatsuki M, et al. (2008) A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol 15: 2934-2942.
26. Lu S, Wang Y, (2010) Fluorescence resonance energy transfer biosensors for cancer detection and evaluation of drug efficacy. Clin Cancer Res 16: 3822-3824.
27. Jabaiah A, Daugherty PS, (2011) Directed evolution of protease beacons that enable sensitive detection of endogenous MT1-MMP activity in tumor cell lines. Chem Biol 18: 392-401.
28. Packard BZ, Artym VV, Komoriya A, Yamada KM, (2009) Direct visualization of protease activity on cells migrating in three-dimensions. Matrix Biol 28: 3-10.
29. Ouyang M, Lu S, Li XY, Xu J, Seong J, et al. (2008) Visualization of polarized membrane type 1 matrix metalloproteinase activity in live cells by fluorescence resonance energy transfer imaging. J Biol Chem 283: 17740-17748.
30. Ouyang M, Huang H, Shaner NC, Remacle AG, Shiryaev SA, et al. (2010) Simultaneous visualization of protumorigenic Src and MT1-MMP activities with fluorescence resonance energy transfer. Cancer Res 70: 2204-2212.
31. Ratnikov B, Cieplak P, Smith JW, (2009) High throughput substrate phage display for protease profiling. Methods Mol Biol 539: 93-114.
32. Komatsu N, Aoki K, Yamada M, Yukinaga H, Fujita Y, et al. (2011) Development of an optimized backbone of FRET biosensors for kinases and GTPases. Mol Biol Cell 22: 4647-4656.
33. Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, et al. (1998) Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket. J Med Chem 41: 1209-1217.
34. Grobelny D, Poncz L, Galardy RE, (1992) Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 31: 7152-7154.
35. Madsen DH, Ingvarsen S, Jurgensen HJ, Melander MC, Kjoller L, et al. (2011) The non-phagocytic route of collagen uptake: a distinct degradation pathway. J Biol Chem 286: 26996-27010.
36. Yana I, Seiki M, (2002) MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis 19: 209-215.
37. Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, et al. (2006) Circulating MMP2 and MMP9 in breast cancer-- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 119: 1403-1411.
38. Wang Y, Shyy JY, Chien S, (2008) Fluorescence proteins, live-cell imaging, and mechanobiology: seeing is believing. Annu Rev Biomed Eng 10: 1-38.
39. Kovarik ML, Allbritton NL, (2011) Measuring enzyme activity in single cells. Trends Biotechnol 29: 222-230.
40. Qin Y, Dittmer PJ, Park JG, Jansen KB, Palmer AE, (2011) Measuring steady-state and dynamic endoplasmic reticulum and Golgi Zn2+ with genetically encoded sensors. Proc Natl Acad Sci U S A 108: 7351-7356.
41. Spiller DG, Wood CD, Rand DA, White MR, (2010) Measurement of single-cell dynamics. Nature 465: 736-745.
42. Lafleur MA, Mercuri FA, Ruangpanit N, Seiki M, Sato H, et al. (2006) Type I collagen abrogates the clathrin-mediated internalization of membrane type 1 matrix metalloproteinase (MT1-MMP) via the MT1-MMP hemopexin domain. J Biol Chem 281: 6826-6840.
43. Itoh Y, Palmisano R, Anilkumar N, Nagase H, Miyawaki A, et al. (2011) Dimerization of MT1-MMP during cellular invasion detected by fluorescence resonance energy transfer. Biochem J 440: 319-326.
44. Ouyang M, Sun J, Chien S, Wang Y, (2008) Determination of hierarchical relationship of Src and Rac at subcellular locations with FRET biosensors. Proc Natl Acad Sci U S A 105: 14353-14358.
45. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC, (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66: 3034-3043.
46. Masters JR, (2002) HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2: 315-319.
47. Zhai Y, Hotary KB, Nan B, Bosch FX, Munoz N, et al. (2005) Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res 65: 6543-6550.
48. Brekhman V, Neufeld G, (2009) A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion. BMC Cancer 9: 415.
49. Pulyaeva H, Bueno J, Polette M, Birembaut P, Sato H, et al. (1997) MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 15: 111-120.
50. Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, et al. (2009) Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 9: 20.
51. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, et al. (2001) Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61: 5168-5178.
52. Devy L, Huang L, Naa L, Yanamandra N, Pieters H, et al. (2009) Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res 69: 1517-1526.
53. Binder C, Hagemann T, Husen B, Schulz M, Einspanier A, (2002) Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Mol Hum Reprod 8: 789-796.
54. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, et al. (2001) Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U S A 98: 13693-13698.
55. Jang JY, Jeon YK, Kim CW, (2010) Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. BMC Cancer 10: 391.
56. Rezaeipoor R, John R, Adie SG, Chaney EJ, Marjanovic M, et al. (2009) Fc-directed antibody conjugation of magnetic nanoparticles for enhanced molecular targeting. J Innov Opt Health Sci 2: 387-396.